Skip to main content

Table 2 Participants drug intake

From: Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case–control study

 

n missing (%)

Case

n (%)

Control

n (%)

OR (95 %-CI)a

Total

 

37 (22.8)

125 (77.2)

 

DMARD

    

 No

10 (6.17)

5 (14.3)

20 (17.1)

1.00 (Ref.)

 Yes

 

30 (85.7)

97 (82.9)

1.25 (0.42;3.76)

Immunosuppressives

    

 No

21 (12.96)

11 (35.5)

39 (35.5)

1.00 (Ref.)

 Yes

 

20 (64.5)

71 (64.6)

0.97 (0.42;2.27)

Cytostatics

    

 No

42 (25.93)

27 (93.1)

86 (94.5)

1.00 (Ref.)

 Yes

 

2 (6.9)

5 (5.5)

1.29 (0.23;7.18)

Glucocorticoids

    

 No

26 (16.05)

7 (21.2)

39 (37.9)

1.00 (Ref.)

 Yes

 

26 (78.8)

64 (62.1)

2.31 (0.88;6.10)

Biologics

    

 No

38 (23.46)

25 (86.2)

74 (77.9)

1.00 (Ref.)

 Yes

 

4 (13.8)

21 (22.1)

0.75 (0.24;2.38)

  1. OR odds ratio, CI confidence interval, DMARD disease-modifying anti-rheumatic drugs
  2. aOR of conditional (fixed-effects) logistic regression analysis with cancer (yes/no) as outcome. For each independent variable a separate model was created